These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3152399)

  • 1. Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method.
    Itoh K; Yasuda Y; Suzuki O; Itoh H; Itoh T; Tsao JW; Konishi T; Koyano A
    J Clin Ultrasound; 1988 Oct; 16(8):553-62. PubMed ID: 3152399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound attenuation measurements of the liver in vivo using a commercial sector scanner.
    Garra BS; Shawker TH; Nassi M; Russell MA
    Ultrason Imaging; 1984 Oct; 6(4):396-407. PubMed ID: 6399170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat.
    Taylor KJ; Riely CA; Hammers L; Flax S; Weltin G; Garcia-Tsao G; Conn HO; Kuc R; Barwick KW
    Radiology; 1986 Jul; 160(1):65-71. PubMed ID: 3520657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method.
    Fujii Y; Taniguchi N; Itoh K; Shigeta K; Wang Y; Tsao JW; Kumasaki K; Itoh T
    J Ultrasound Med; 2002 Jul; 21(7):783-8. PubMed ID: 12099567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurements of frequency-dependent attenuation in tumors of the liver.
    Dong BW; Wang M; Xie K; Chen MH
    J Clin Ultrasound; 1994; 22(3):167-74. PubMed ID: 8169236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo measurements of ultrasound attenuation in normal or diseased liver.
    Parker KJ; Asztely MS; Lerner RM; Schenk EA; Waag RC
    Ultrasound Med Biol; 1988; 14(2):127-36. PubMed ID: 3279691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of ultrasonic attenuation with pathologic fat and fibrosis in liver disease.
    Lin T; Ophir J; Potter G
    Ultrasound Med Biol; 1988; 14(8):729-34. PubMed ID: 3062866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency domain processing for ultrasonic attenuation measurement in liver.
    Wilson LS; Robinson DE; Doust BD
    Ultrason Imaging; 1984 Jul; 6(3):278-92. PubMed ID: 6396922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems of the "normal" liver scan].
    Bublitz G; Herzer R; Riebel TH
    Fortschr Geb Rontgenstr Nuklearmed; 1973 May; 118(5):578-84. PubMed ID: 4352568
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear magnetic resonance of the liver, spleen, and pancreas.
    Stark DD; Moss AA; Goldberg HI
    Cardiovasc Intervent Radiol; 1986; 8(5-6):329-41. PubMed ID: 3009015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound backscatter and attenuation in human liver with diffuse disease.
    Lu ZF; Zagzebski JA; Lee FT
    Ultrasound Med Biol; 1999 Sep; 25(7):1047-54. PubMed ID: 10574336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver.
    Wilson LS; Robinson DE; Griffiths KA; Manoharan A; Doust BD
    Ultrason Imaging; 1987 Oct; 9(4):236-47. PubMed ID: 3330337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver and spleen scintiscanning with indium 113m. A clinical pathologic correlation.
    Potchen EJ; Adatepe M
    Am J Roentgenol Radium Ther Nucl Med; 1969 Aug; 106(4):739-44. PubMed ID: 4308790
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic accuracy of computerized B-scan texture analysis and conventional ultrasonography in diffuse parenchymal and malignant liver disease.
    Raeth U; Schlaps D; Limberg B; Zuna I; Lorenz A; van Kaick G; Lorenz WJ; Kommerell B
    J Clin Ultrasound; 1985 Feb; 13(2):87-99. PubMed ID: 3920275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonic attenuation maps of liver based on a conventional B-scan and an amplitude loss technique.
    Shmulewitz A; Heyman Z; Walach E; Ramot B; Itzchak Y
    Invest Radiol; 1990 Oct; 25(10):1095-101. PubMed ID: 2079408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between hepatic vein pressure and diameter of portal vein and spleen as determined by ultrasound tomography in patients with liver disease (author's transl)].
    Strohm WD; Uher B
    Z Gastroenterol; 1979 Oct; 17(10):695-703. PubMed ID: 524946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound in the diagnostics of fatty liver in obesity].
    Szebeni A; Tolvaj G; Stotz G
    Orv Hetil; 2010 Apr; 151(14):572-5. PubMed ID: 20332074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of ultrasound attenuation and histopathological parameters of the liver in chronic diffuse liver diseases.
    Szebeni A; Tolvaj G; Zalatnai A
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):37-42. PubMed ID: 16357617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnosis of chronic liver disease using radio-colloid scanning (author's transl)].
    Sauer R; Fridrich R; Fahrländer H
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Aug; 119(2):175-84. PubMed ID: 4357580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.